Table 9.
Ongoing clinical trials for evaluation of Mesenchymal Stem Cell Therapy.
| Clinical Trial Number | Study Description | Phase | Dose | Location |
|---|---|---|---|---|
| NCT04348435 | Clinical Trial for Determination of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Therapy | 2 | 200 million cells in each dose | United States |
| NCT04349631 | Determining the Safety and Efficacy of Autologous Mesenchymal Stem Cell Therapy | 2 | Five I.V. infusion | United States |
| NCT04341610 | Evaluating the use of Allogeneic adipose-derived mesenchymal stromal cell Therapy | 1,2 | 100 million cells diluted in 100 ml saline | Denmark |
| NCT04313322 | Wharton's Jelly-Mesenchymal Stem Cells therapy for COVID-19 patients | 1 | WJ-MSCs suspended in 25 ml of a Saline solution which contains 0.5% human Serum Albumin | Jordan |
| NCT04288102 | Evaluating the use of Mesenchymal Stem Cells | 2 | 4.0*10E7 cells per time | China |
| NCT04346368 | Evaluating utilization of Bone Marrow-Derived Mesenchymal Stem Cell Treatment | 1,2 | 1*10E6/kg body weight | China |
| NCT04339660 | Evaluation of the use of Human Mesenchymal Stem Cells | 1,2 | 1*10E6 UC-MSCs/kg body weight after suspending in 100 ml saline | China |
| NCT04333368 | Evaluation of Umbilical cord-derived Mesenchymal Stromal Cells | 1,2 | 1 Million/kg | France |
| NCT04361942 | Allogeneic Mesenchymal Stromal Cells evaluation for use against COVID-19 infection | 2 | 1 million MSV cells/kg in 100 ml of saline | Spain |